Phase 2 Lung Disease Clinical Trials
34 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 34 trials
Recruiting
Phase 2
Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease
Interstitial Lung Disease (ILD)
Region Skane20 enrolled2 locationsNCT07398287
Recruiting
Phase 2
A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients
Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)
Sunshine Lake Pharma Co., Ltd.110 enrolled1 locationNCT05139719
Recruiting
Phase 2
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Cardiovascular DiseasesFibrosisLung Diseases+3 more
Pulmovant, Inc.20 enrolled1 locationNCT07333183
Recruiting
Phase 2
Collagen-targeted PET Imaging for Early Interstitial Lung Disease
Interstitial Lung Disease
Massachusetts General Hospital30 enrolled1 locationNCT05417776
Recruiting
Phase 1Phase 2
Feasibility of Semaglutide in Advanced Lung Disease
ObesityChronic Obstructive Pulmonary DiseaseInterstitial Lung Disease+2 more
University of Pennsylvania8 enrolled1 locationNCT05746039
Recruiting
Phase 1Phase 2
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd.118 enrolled4 locationsNCT07407933
Recruiting
Phase 2
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Progressive Pulmonary FibrosisInterstitial Lung DiseasePulmonary Fibrosis+4 more
Avalyn Pharma Inc.375 enrolled152 locationsNCT06329401
Recruiting
Phase 2
Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease
Lung CancerInterstitial Lung Disease
David Palma98 enrolled3 locationsNCT05986318
Recruiting
Phase 2
H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
Interstitial Lung DiseaseLung Diseases, InterstitialIdiopathic Pulmonary Fibrosis
National Institute of Environmental Health Sciences (NIEHS)37 enrolled1 locationNCT06325696
Recruiting
Phase 2
Pulmonary Hypertension SOLAR
COPDInterstitial Lung DiseasePulmonary Arterial Hypertension
Bastiaan Driehuys30 enrolled1 locationNCT04778046
Recruiting
Phase 2Phase 3
Anlotinib Capsules in the Treatment for IPF/PF-ILDs
Interstitial Lung Diseases
First Affiliated Hospital of Wenzhou Medical University30 enrolled1 locationNCT05828953
Recruiting
Phase 2
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Lung DiseasesBronchiolitis Obliterans SyndromeChronic Graft Versus Host Disease+1 more
Dana-Farber Cancer Institute45 enrolled5 locationsNCT05922761
Recruiting
Phase 2
Platform Clinical Study for Conquering Scleroderma
SclerodermaInterstitial Lung Disease Due to Systemic Disease
Scleroderma Research Foundation, Inc.400 enrolled34 locationsNCT06195072
Recruiting
Phase 2
129Xe MRI Cardiopulmonary
DyspneaInterstitial Lung DiseaseAnemia+3 more
Bastiaan Driehuys125 enrolled1 locationNCT06038630
Recruiting
Phase 2
Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough
Interstitial Lung Disease
Mayo Clinic25 enrolled1 locationNCT05120934
Recruiting
Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
Interstitial Lung Disease
Bastiaan Driehuys445 enrolled1 locationNCT01280994
Recruiting
Phase 2Phase 3
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Scleroderma, SystemicSystemic Sclerosis Associated Interstitial Lung Disease
GlaxoSmithKline300 enrolled131 locationsNCT05878717
Recruiting
Phase 2
Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer
Lung NeoplasmsThoracic NeoplasmsLung Diseases+1 more
Shanghai Pulmonary Hospital, Shanghai, China15 enrolled1 locationNCT06758700
Recruiting
Phase 2
Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Xenopi Pulmonary Infection
Lung DiseasesMycobacterium; Xenopi
Centre Hospitalier Universitaire, Amiens190 enrolled1 locationNCT06585020
Recruiting
Phase 2
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
Interstitial Lung DiseaseCommon Variable Immunodeficiency
Children's Hospital Medical Center, Cincinnati38 enrolled6 locationsNCT04925375